Prof Ros Gleadow FAA

16.9K posts

Prof Ros Gleadow FAA banner
Prof Ros Gleadow FAA

Prof Ros Gleadow FAA

@RosGleadow

#climatechange, plants that kill, #MECFS ally - views my own - #PlantSci #cyanide #WomeninSTEM Mostly reposting. New stuff on @rgleadow.bsky.social

Melbourne/Naarm Katılım Eylül 2009
1.7K Takip Edilen3.4K Takipçiler
Prof Ros Gleadow FAA retweetledi
Putrino Lab
Putrino Lab@PutrinoLab·
Great win early in the year to receive notification that our case series looking into Dr Pridgen’s Valacyclovir, Celecoxib and Paxlovid protocol seems to really help some folks with #LongCOVID. This paper is a start, not the be-all and end-all: frontiersin.org/journals/immun… 1/
English
10
115
493
22.2K
Prof Ros Gleadow FAA retweetledi
Emerge Australia
Emerge Australia@EmergeAus·
🌍 Free, self-paced education for people with #MECFS, #LongCOVID and other energy-limiting conditions. Our new Learning & Education Centre with Bateman Horne Center covers PEM, pacing, orthostatic intolerance + daily life strategies. Start here: zurl.co/Qm1EB
Emerge Australia tweet media
English
0
1
4
120
Prof Ros Gleadow FAA retweetledi
Dr Monique Ryan MP
Dr Monique Ryan MP@Mon4Kooyong·
Excessive cutting back of nature strips’ tree canopy contributes to urban heat islands, damages trees, goes against expert advice, and costs ratepayers millions of dollars. The Allan state govt needs to drop its evidence-free red tape and wind back regulations on suburban tree pruning. theage.com.au/national/victo…
English
112
25
156
19.9K
Prof Ros Gleadow FAA retweetledi
Harry Spoelstra
Harry Spoelstra@HarrySpoelstra·
Vascular Complications of Long COVID—From Endothelial Dysfunction to Systemic Thrombosis 🔥 And again, now an interesting Serbian systematic narrative review synthesizing current evidence on vascular dysfunction, coagulopathy, and thromboembolic complications associated with post-acute sequelae of SARS-CoV-2 infection: #LC ➡️"LC has emerged as a complex multisystem condition in which persistent vascular dysfunction appears to represent a key pathogenic component." ➡️"Chronic inflammation, immune dysregulation, endothelial injury, and sustained activation of coagulation pathways collectively contribute to the development of microvascular and macrovascular abnormalities long after the resolution of acute infection." ➡️"Mechanisms such as endotheliitis, activation of the complement cascade, formation of fibrinolysis-resistant microclots, platelet hyperactivation, and involvement of the autonomic nervous system promote impaired perfusion, tissue hypoxia, and a broad spectrum of clinical manifestations. Microvascular rarefaction, capillary dilatation, microhemorrhages, and reduced flow-mediated responses have been widely documented and correlate with neurological, cardiovascular, and acral symptoms observed in patients with LC." ➡️Clinical Risks: - Increased incidence of venous thromboembolism (DVT, PE; hazard ratios up to 2.93), - Arterial events (MI, Stroke; up to 3.16), - Arrhythmias, - Myocarditis, and - Heart failure, - Risks persisting up to at least 1 year post-infection, especially in severe cases or high-risk groups, but even MILD cases can carry these risks!. ➡️"Growing evidence suggests that the vascular component provides a unifying framework linking many of the persistent symptoms and complications associated with LC." ➡️"A deeper understanding of these interconnected mechanisms is essential for early recognition, risk stratification, and individualized management of affected patients." ➡️"Further research is needed to identify reliable biomarkers, determine individuals at greatest risk, and develop effective therapeutic strategies aimed at supporting endothelial recovery, modulating immune activation, and restoring microcirculatory function." ➡️"Future interventional studies should clarify whether therapies targeting endothelial repair, microthrombotic burden, or autonomic imbalance can modify the long-term trajectory of LC, ideally within multidisciplinary care pathways involving cardiology, hematology, neurology, and rehabilitation services." ‼️So, for those sitting at the back, Long COVID drives persistent vascular complications through SARS-CoV-2-induced endothelial dysfunction and thromboinflammation, markedly elevating risks of thrombosis, stroke, myocardial infarction, and heart failure for at least one year post-infection! ‼️Awaiting studies on multiple infections, with the added/cumulative risks from these reinfections. ‼️Meanwhile this review AGAIN emphasizes endothelial dysfunction as the pathophysiological link driving long-term vascular morbidity in LC! mdpi.com/1422-0067/27/1…
Harry Spoelstra tweet media
English
5
105
303
9.2K
Prof Ros Gleadow FAA retweetledi
Mike Honey
Mike Honey@Mike_Honey_·
Here's my "2025 - Year in Review". I'm really looking forward to 2026! My New Years Resolution: make more folders. youtube.com/watch?v=ctTQBX…
YouTube video
YouTube
English
9
13
69
3.7K
Prof Ros Gleadow FAA
Prof Ros Gleadow FAA@RosGleadow·
Time to switch off the socials for my annual Digital Detox - might not come back
English
0
0
0
59
Prof Ros Gleadow FAA
Prof Ros Gleadow FAA@RosGleadow·
@fitterhappierAJ My last infection was 3 weeks post vaccination. I took antivirals and was not nearly as sick as last time - but 10 days later was exhausted for about a month. I rested and took everything I could think of to reduce the risk of LC. Feeling good now 3 months later 🤞
English
0
0
7
107
AJ Leonardi, MBBS, PhD
AJ Leonardi, MBBS, PhD@fitterhappierAJ·
Wonderful descriptive depiction. One take-home is that if you are getting infections despite vaccination, there is an evident, and high chance of long covid manifestation in bodily systems I will make a thread on the charlatans who said long covid was less than 5% later
Harry Spoelstra@HarrySpoelstra

Estimating risk of long COVID using a Bayesian network-based decision support tool 🤔Do you want to know your LC and other C19 risks?( Great Australian work!)👇 ➡️"Vaccination, receiving drug treatment within three days of acute infection, and avoiding repeated infections are the greatest modifiable influences of long COVID development, decreasing risk by up to 63 % under modelled scenarios." ➡️Here an "interactive user-friendly web-based decision support tool : corical.immunisationcoalition.org.au/longcovid enabling easy access to model outputs, and allows individuals to calculate their personalised probability of long COVID under different scenarios of modifiable risk factors." ➡️"The decision-support tool can be used by individuals or in conjunction with clinicians for shared decision-making on vaccination, pursuing early drug treatment during acute infection, and continuing protective behaviors such as masking and social distancing." ➡️"The model can also generate population-level estimates of outcomes to assist public health decision-makers to design better-informed public health policies." ‼️Sit down.......and take the test...... ooooooeps!!. sciencedirect.com/science/articl…

English
10
172
609
20.4K
Prof Ros Gleadow FAA retweetledi
Todd Davenport
Todd Davenport@sunsopeningband·
I find that people interviewing me are surprised when I, as a clinician-scholar am very plain about fairly non-controversial items like “ME is complex and verifiably biological” and “ME is not deconditioning” and “ME ruins lives.” These things, at least, are settled science.
English
1
15
131
1.6K
Prof Ros Gleadow FAA retweetledi
Jess 🇨🇦
Jess 🇨🇦@MeetJess·
Why scientists are rethinking the immune effects of SARS-CoV-2 « A growing number of scientists believe that the SARS-CoV-2 virus may instead be subtly altering our immune systems » The proof is all around us … bmj.com/content/390/bm…
English
45
369
1.2K
114.8K